GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OTCPK:BVNRY) » Definitions » Net-Net Working Capital
中文

Bavarian Nordic A/S (Bavarian Nordic A/S) Net-Net Working Capital : $0.01 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Bavarian Nordic A/S's Net-Net Working Capital for the quarter that ended in Dec. 2023 was $0.01.

The industry rank for Bavarian Nordic A/S's Net-Net Working Capital or its related term are showing as below:

BVNRY's Price-to-Net-Net-Working-Capital is ranked worse than
100% of 931 companies
in the Biotechnology industry
Industry Median: 4.08 vs BVNRY: 715.00

Bavarian Nordic A/S Net-Net Working Capital Historical Data

The historical data trend for Bavarian Nordic A/S's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.61 -1.71 -0.34 -1.04 0.01

Bavarian Nordic A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.04 0.04 -1.36 -0.50 0.01

Competitive Comparison

For the Biotechnology subindustry, Bavarian Nordic A/S's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bavarian Nordic A/S Price-to-Net-Net-Working-Capital Distribution

For the Biotechnology industry and Healthcare sector, Bavarian Nordic A/S's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Bavarian Nordic A/S's Price-to-Net-Net-Working-Capital falls into.



Bavarian Nordic A/S Net-Net Working Capital Calculation

Bavarian Nordic A/S's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net-Net Working Capital(A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(273.231+0.75 * 260.155+0.5 * 240.495-587.183
-0-0)/233.832
=0.01

Bavarian Nordic A/S's Net-Net Working Capital (NNWC) per share for the quarter that ended in Dec. 2023 is calculated as

Net-Net Working Capital(Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(273.231+0.75 * 260.155+0.5 * 240.495-587.183
-0-0)/233.832
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Bavarian Nordic A/S  (OTCPK:BVNRY) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Bavarian Nordic A/S Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Bavarian Nordic A/S (Bavarian Nordic A/S) Business Description

Traded in Other Exchanges
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (Bavarian Nordic A/S) Headlines

From GuruFocus

Q2 2022 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2023 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2018 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2020 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2019 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Bavarian Nordic A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Bavarian Nordic A/S - Special Call Transcript

By GuruFocus Research 02-13-2024